A Study of E7050 Administered Orally to Patients With Advanced Solid Tumors

NCT00921869 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
16
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Eisai Co., Ltd.